Volume 77, April 2026, 152912Author links open overlay panelSung Hae Chang a, Misti L. Paudel b c, Eun Young Lee d, Jeffrey A. Sparks b cShow moreAccess through your organization

Check access to the full text by signing in through your organization.

Access through your organizationSection snippetsDeclaration of competing interest

Dr. Lee reports research funding from the National Research Foundation of Korea; consulting fees from IMBiologics and Samsung Bioepis; and honoraria from AbbVie, Samsung Bioepis, Boerhinger Ingelheim Korea, Novartis Korea, and Janssen Korea. Dr. Sparks has received research support from the National Institutes of Health, the Arthritis Foundation, Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, and Sonoma Biotherapeutics unrelated to this work. He has performed consultancy for

References (2)S.H. Chang et al.Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: the prospective KORAIL cohort

Semin Arthritis Rheum

(2025)

G.S. Collins et al.Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

Ann Intern Med

(2015)

View full text

© 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.